Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 65 entries
Sorted by: Best Match Show Resources per page
Electrochemotherapy in melanoma patients: a single institution experience.

Melanoma management

Caracò C, Marone U, Simeone E, Grimaldi AM, Botti G, Del Giudice M, Ascierto PA, Mozzillo N.
PMID: 30190842
Melanoma Manag. 2015 May;2(2):127-132. doi: 10.2217/mmt.15.9. Epub 2015 May 18.

AIM: This study was undertaken to update the outcome of the treated lesions with electrochemotherapy (ECT) plus intravenous injection of bleomycin in patients with in-transit disease or distant cutaneous metastases in melanoma patients.PATIENTS & METHODS: 89 patients with relapsed...

Cite
Caracò C, Marone U, Simeone E, et al. Electrochemotherapy in melanoma patients: a single institution experience. Melanoma Manag. 2015;2(2):127-132doi: 10.2217/mmt.15.9.
Caracò, C., Marone, U., Simeone, E., Grimaldi, A. M., Botti, G., Del Giudice, M., Ascierto, P. A., & Mozzillo, N. (2015). Electrochemotherapy in melanoma patients: a single institution experience. Melanoma management, 2(2), 127-132. https://doi.org/10.2217/mmt.15.9
Caracò, Corrado, et al. "Electrochemotherapy in melanoma patients: a single institution experience." Melanoma management vol. 2,2 (2015): 127-132. doi: https://doi.org/10.2217/mmt.15.9
Caracò C, Marone U, Simeone E, Grimaldi AM, Botti G, Del Giudice M, Ascierto PA, Mozzillo N. Electrochemotherapy in melanoma patients: a single institution experience. Melanoma Manag. 2015 May;2(2):127-132. doi: 10.2217/mmt.15.9. Epub 2015 May 18. PMID: 30190842; PMCID: PMC6094613.
Copy Download .nbib Format: NLM
Advanced technologies for the remediation of pesticide-contaminated soils.

The Science of the total environment

Morillo E, Villaverde J.
PMID: 28214125
Sci Total Environ. 2017 May 15;586:576-597. doi: 10.1016/j.scitotenv.2017.02.020. Epub 2017 Feb 15.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies that have been tested at full-scale. The aim of...

Cite
Morillo E, Villaverde J. Advanced technologies for the remediation of pesticide-contaminated soils. Sci Total Environ. 2017;586:576-597doi: 10.1016/j.scitotenv.2017.02.020.
Morillo, E., & Villaverde, J. (2017). Advanced technologies for the remediation of pesticide-contaminated soils. The Science of the total environment, 586576-597. https://doi.org/10.1016/j.scitotenv.2017.02.020
Morillo, E, and Villaverde, J. "Advanced technologies for the remediation of pesticide-contaminated soils." The Science of the total environment vol. 586 (2017): 576-597. doi: https://doi.org/10.1016/j.scitotenv.2017.02.020
Morillo E, Villaverde J. Advanced technologies for the remediation of pesticide-contaminated soils. Sci Total Environ. 2017 May 15;586:576-597. doi: 10.1016/j.scitotenv.2017.02.020. Epub 2017 Feb 15. PMID: 28214125.
Copy Download .nbib Format: NLM
Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study.

Neurology

Provitera V, Iodice V, Manganelli F, Mozzillo S, Caporaso G, Stancanelli A, Borreca I, Esposito M, Dubbioso R, Iodice R, Vitale F, Koay S, Vichayanrat E, Valerio F, Santoro L, Nolano M.
PMID: 35017309
Neurology. 2022 Jan 11; doi: 10.1212/WNL.0000000000013300. Epub 2022 Jan 11.

BACKGROUND AND OBJECTIVES: Sudomotor impairment has been recognized as a key feature in differentiating Parkinson disease (PD) and multiple system atrophy-parkinsonian type (MSA-P) with the latter been characterized by diffuse anhidrosis in prospective study including patients in late stage...

Cite
Provitera V, Iodice V, Manganelli F, et al. Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study. Neurology. 2022;doi: 10.1212/WNL.0000000000013300.
Provitera, V., Iodice, V., Manganelli, F., Mozzillo, S., Caporaso, G., Stancanelli, A., Borreca, I., Esposito, M., Dubbioso, R., Iodice, R., Vitale, F., Koay, S., Vichayanrat, E., Valerio, F., Santoro, L., & Nolano, M. (2022). Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study. Neurology, . https://doi.org/10.1212/WNL.0000000000013300
Provitera, Vincenzo, et al. "Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study." Neurology vol. (2022). doi: https://doi.org/10.1212/WNL.0000000000013300
Provitera V, Iodice V, Manganelli F, Mozzillo S, Caporaso G, Stancanelli A, Borreca I, Esposito M, Dubbioso R, Iodice R, Vitale F, Koay S, Vichayanrat E, Valerio F, Santoro L, Nolano M. Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study. Neurology. 2022 Jan 11; doi: 10.1212/WNL.0000000000013300. Epub 2022 Jan 11. PMID: 35017309.
Copy Download .nbib Format: NLM
Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).

Frontiers in endocrinology

Mozzillo E, Franceschi R, Piona C, Passanisi S, Casertano A, Pjetraj D, Maltoni G, Calcaterra V, Cauvin V, Cherubini V, D'Annunzio G, Franzese A, Frongia AP, Lombardo F, Lo Presti D, Matteoli MC, Piccinno E, Predieri B, Rabbone I, Scaramuzza AE, Toni S, Zucchini S, Maffeis C, Schiaffini R.
PMID: 34017312
Front Endocrinol (Lausanne). 2021 Apr 29;12:673539. doi: 10.3389/fendo.2021.673539. eCollection 2021.

Cystic fibrosis related diabetes (CFRD) is a comorbidity of cystic fibrosis (CF) that negatively impacts on its clinical course. Prediabetes is an important predictor of either CFRD development and unfavorable prognosis of CF in both pediatric and adult patients....

Cite
Mozzillo E, Franceschi R, Piona C, et al. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED). Front Endocrinol (Lausanne). 2021;12:673539doi: 10.3389/fendo.2021.673539.
Mozzillo, E., Franceschi, R., Piona, C., Passanisi, S., Casertano, A., Pjetraj, D., Maltoni, G., Calcaterra, V., Cauvin, V., Cherubini, V., D'Annunzio, G., Franzese, A., Frongia, A. P., Lombardo, F., Lo Presti, D., Matteoli, M. C., Piccinno, E., Predieri, B., Rabbone, I., Scaramuzza, A. E., Toni, S., Zucchini, S., Maffeis, C., & Schiaffini, R. (2021). Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED). Frontiers in endocrinology, 12673539. https://doi.org/10.3389/fendo.2021.673539
Mozzillo, Enza, et al. "Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED)." Frontiers in endocrinology vol. 12 (2021): 673539. doi: https://doi.org/10.3389/fendo.2021.673539
Mozzillo E, Franceschi R, Piona C, Passanisi S, Casertano A, Pjetraj D, Maltoni G, Calcaterra V, Cauvin V, Cherubini V, D'Annunzio G, Franzese A, Frongia AP, Lombardo F, Lo Presti D, Matteoli MC, Piccinno E, Predieri B, Rabbone I, Scaramuzza AE, Toni S, Zucchini S, Maffeis C, Schiaffini R. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED). Front Endocrinol (Lausanne). 2021 Apr 29;12:673539. doi: 10.3389/fendo.2021.673539. eCollection 2021. PMID: 34017312; PMCID: PMC8130616.
Copy Download .nbib Format: NLM
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study.

Frontiers in oncology

Monari C, Sagnelli C, Maggi P, Sangiovanni V, Numis FG, Gentile I, Masullo A, Rescigno C, Calabria G, Megna AS, Gambardella M, Manzillo E, Russo G, Esposito V, Camaioni C, Messina V, Pisaturo M, Allegorico E, Pinchera B, Pisapia R, Catalano M, Salzillo A, Porta G, Signoriello G, Coppola N.
PMID: 34026639
Front Oncol. 2021 May 07;11:662746. doi: 10.3389/fonc.2021.662746. eCollection 2021.

BACKGROUND: The aim of the study was to compare coronavirus disease 2019 (COVID-19) severity presentation between oncologic and non-oncologic patients and to evaluate the impact of cancer type and stage on COVID-19 course.METHODS: We performed a multicentre, retrospective study...

Cite
Monari C, Sagnelli C, Maggi P, et al. More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study. Front Oncol. 2021;11:662746doi: 10.3389/fonc.2021.662746.
Monari, C., Sagnelli, C., Maggi, P., Sangiovanni, V., Numis, F. G., Gentile, I., Masullo, A., Rescigno, C., Calabria, G., Megna, A. S., Gambardella, M., Manzillo, E., Russo, G., Esposito, V., Camaioni, C., Messina, V., Pisaturo, M., Allegorico, E., Pinchera, B., Pisapia, R., Catalano, M., Salzillo, A., Porta, G., Signoriello, G., & Coppola, N. (2021). More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study. Frontiers in oncology, 11662746. https://doi.org/10.3389/fonc.2021.662746
Monari, Caterina, et al. "More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study." Frontiers in oncology vol. 11 (2021): 662746. doi: https://doi.org/10.3389/fonc.2021.662746
Monari C, Sagnelli C, Maggi P, Sangiovanni V, Numis FG, Gentile I, Masullo A, Rescigno C, Calabria G, Megna AS, Gambardella M, Manzillo E, Russo G, Esposito V, Camaioni C, Messina V, Pisaturo M, Allegorico E, Pinchera B, Pisapia R, Catalano M, Salzillo A, Porta G, Signoriello G, Coppola N. More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study. Front Oncol. 2021 May 07;11:662746. doi: 10.3389/fonc.2021.662746. eCollection 2021. PMID: 34026639; PMCID: PMC8139554.
Copy Download .nbib Format: NLM
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.

The Journal of dermatological treatment

Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Peccianti C, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavo SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Stingeni L, Caruso C, Argenziano G.
PMID: 32436765
J Dermatolog Treat. 2020 Jul 03;1-4. doi: 10.1080/09546634.2020.1773379. Epub 2020 Jul 03.

No abstract available.

Cite
Fargnoli MC, Esposito M, Ferrucci S, et al. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. J Dermatolog Treat. 2020;1-4doi: 10.1080/09546634.2020.1773379.
Fargnoli, M. C., Esposito, M., Ferrucci, S., Girolomoni, G., Offidani, A., Patrizi, A., Peris, K., Costanzo, A., Malara, G., Pellacani, G., Romanelli, M., Amerio, P., Cristaudo, A., Flori, M. L., Motolese, A., Betto, P., Patruno, C., Pigatto, P., Peccianti, C., Stinco, G., Zalaudek, I., Bianchi, L., Boccaletti, V., Cannavo, S. P., Cusano, F., Lembo, S., Mozzillo, R., Gallo, R., Potenza, C., Rongioletti, F., Tiberio, R., Grieco, T., Micali, G., Persechino, S., Pettinato, M., Pucci, S., Stingeni, L., Caruso, C., & Argenziano, G. (2020). A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. The Journal of dermatological treatment, 1-4. https://doi.org/10.1080/09546634.2020.1773379
Fargnoli, M C, et al. "A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis." The Journal of dermatological treatment vol. (2020): 1-4. doi: https://doi.org/10.1080/09546634.2020.1773379
Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Peccianti C, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavo SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Stingeni L, Caruso C, Argenziano G. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. J Dermatolog Treat. 2020 Jul 03;1-4. doi: 10.1080/09546634.2020.1773379. Epub 2020 Jul 03. PMID: 32436765.
Copy Download .nbib Format: NLM
Type 2 diabetes in pediatrics.

Minerva pediatrics

Fornari E, Barbetti F, Iafusco D, Lombardo F, Miraglia Del Giudice E, Rabbone I, Mozzillo E.
PMID: 34286947
Minerva Pediatr (Torino). 2021 Jul 21; doi: 10.23736/S2724-5276.21.06530-7. Epub 2021 Jul 21.

Type 2 diabetes (T2D) in adolescents has become an increasing health concern throughout the world and its prevention and screening should be implemented in pediatric care. As clinical features at presentation, in some cases can be similar to type...

Cite
Fornari E, Barbetti F, Iafusco D, et al. Type 2 diabetes in pediatrics. Minerva Pediatr (Torino). 2021;doi: 10.23736/S2724-5276.21.06530-7.
Fornari, E., Barbetti, F., Iafusco, D., Lombardo, F., Miraglia Del Giudice, E., Rabbone, I., & Mozzillo, E. (2021). Type 2 diabetes in pediatrics. Minerva pediatrics, . https://doi.org/10.23736/S2724-5276.21.06530-7
Fornari, Elena, et al. "Type 2 diabetes in pediatrics." Minerva pediatrics vol. (2021). doi: https://doi.org/10.23736/S2724-5276.21.06530-7
Fornari E, Barbetti F, Iafusco D, Lombardo F, Miraglia Del Giudice E, Rabbone I, Mozzillo E. Type 2 diabetes in pediatrics. Minerva Pediatr (Torino). 2021 Jul 21; doi: 10.23736/S2724-5276.21.06530-7. Epub 2021 Jul 21. PMID: 34286947.
Copy Download .nbib Format: NLM
Tautomeric and conformational switching in a new versatile N-rich heterocyclic ligand.

Dalton transactions (Cambridge, England : 2003)

Parisi E, Capasso D, Capobianco A, Peluso A, Di Gaetano S, Fusco S, Manfredi C, Mozzillo R, Pinto G, Centore R.
PMID: 33043951
Dalton Trans. 2020 Oct 27;49(41):14452-14462. doi: 10.1039/d0dt02572k.

A new N-rich triazolo-triazole derivative, 4-methyl-7-(pyrazin-2-yl)-2H-[1,2,4]triazolo[3,2-c][1,2,4]triazole (C8H7N7), bearing a pyrazine residue at 7-position of the triazolo-triazole bicycle, was synthesized, and its acid-base and metal coordination properties were evaluated in solution. The results showed amphoteric behavior and the formation of...

Cite
Parisi E, Capasso D, Capobianco A, et al. Tautomeric and conformational switching in a new versatile N-rich heterocyclic ligand. Dalton Trans. 2020;49(41):14452-14462doi: 10.1039/d0dt02572k.
Parisi, E., Capasso, D., Capobianco, A., Peluso, A., Di Gaetano, S., Fusco, S., Manfredi, C., Mozzillo, R., Pinto, G., & Centore, R. (2020). Tautomeric and conformational switching in a new versatile N-rich heterocyclic ligand. Dalton transactions (Cambridge, England : 2003), 49(41), 14452-14462. https://doi.org/10.1039/d0dt02572k
Parisi, Emmanuele, et al. "Tautomeric and conformational switching in a new versatile N-rich heterocyclic ligand." Dalton transactions (Cambridge, England : 2003) vol. 49,41 (2020): 14452-14462. doi: https://doi.org/10.1039/d0dt02572k
Parisi E, Capasso D, Capobianco A, Peluso A, Di Gaetano S, Fusco S, Manfredi C, Mozzillo R, Pinto G, Centore R. Tautomeric and conformational switching in a new versatile N-rich heterocyclic ligand. Dalton Trans. 2020 Oct 27;49(41):14452-14462. doi: 10.1039/d0dt02572k. PMID: 33043951.
Copy Download .nbib Format: NLM
[Acute and chronic viral hepatitis in HIV positive patients].

Le infezioni in medicina

Izzo CM, Pagliano P, Aprea L, Franco A, Manzillo E, Sbreglia C, Simioli F, Lauro V.
PMID: 14967969
Infez Med. 1996;4(1):32-4.

In this study we evaluated the spreading of HBV, HCV, HDV and HIV among drug user patients. Spreading of hepatotropic viruses resulted high (HBV 84%, HCV 87%, HDV 7%), while spreading of HIV resulted relatively low (18%). During the...

Cite
Izzo CM, Pagliano P, Aprea L, et al. Le epatiti virali acute e croniche in pazienti HIV positivi. [Acute and chronic viral hepatitis in HIV positive patients]. Infez Med. 1996;4(1):32-4
Izzo, C. M., Pagliano, P., Aprea, L., Franco, A., Manzillo, E., Sbreglia, C., Simioli, F., & Lauro, V. (1996). Le epatiti virali acute e croniche in pazienti HIV positivi. [Acute and chronic viral hepatitis in HIV positive patients]. Le infezioni in medicina, 4(1), 32-4.
Izzo, C M, et al. "Le epatiti virali acute e croniche in pazienti HIV positivi." [Acute and chronic viral hepatitis in HIV positive patients]. Le infezioni in medicina vol. 4,1 (1996): 32-4.
Izzo CM, Pagliano P, Aprea L, Franco A, Manzillo E, Sbreglia C, Simioli F, Lauro V. Le epatiti virali acute e croniche in pazienti HIV positivi. [Acute and chronic viral hepatitis in HIV positive patients]. Infez Med. 1996;4(1):32-4. Italian. PMID: 14967969.
Copy Download .nbib Format: NLM
Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma.

Oncoimmunology

Simeone E, Grimaldi AM, Festino L, Giannarelli D, Vanella V, Palla M, Curvietto M, Esposito A, Palmieri G, Mozzillo N, Ascierto PA.
PMID: 28405510
Oncoimmunology. 2017 Jan 19;6(3):e1283462. doi: 10.1080/2162402X.2017.1283462. eCollection 2017.

The optimal sequencing of targeted treatment and immunotherapy in the treatment of advanced melanoma is a key question and prospective studies to address this are ongoing. Previous observations suggest that treating first with targeted therapy may select for more...

Cite
Simeone E, Grimaldi AM, Festino L, et al. Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma. Oncoimmunology. 2017;6(3):e1283462doi: 10.1080/2162402X.2017.1283462.
Simeone, E., Grimaldi, A. M., Festino, L., Giannarelli, D., Vanella, V., Palla, M., Curvietto, M., Esposito, A., Palmieri, G., Mozzillo, N., & Ascierto, P. A. (2017). Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma. Oncoimmunology, 6(3), e1283462. https://doi.org/10.1080/2162402X.2017.1283462
Simeone, Ester, et al. "Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma." Oncoimmunology vol. 6,3 (2017): e1283462. doi: https://doi.org/10.1080/2162402X.2017.1283462
Simeone E, Grimaldi AM, Festino L, Giannarelli D, Vanella V, Palla M, Curvietto M, Esposito A, Palmieri G, Mozzillo N, Ascierto PA. Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma. Oncoimmunology. 2017 Jan 19;6(3):e1283462. doi: 10.1080/2162402X.2017.1283462. eCollection 2017. PMID: 28405510; PMCID: PMC5384373.
Copy Download .nbib Format: NLM
Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report.

Journal of medical case reports

Simeone E, De Maio E, Sandomenico F, Fulciniti F, Lastoria S, Aprea P, Staibano S, Montesarchio V, Palmieri G, Mozzillo N, Ascierto PA.
PMID: 22594466
J Med Case Rep. 2012 May 17;6:131. doi: 10.1186/1752-1947-6-131.

INTRODUCTION: Leptomeningeal metastases are occurring at higher frequency in cancer patients. The prognosis of leptomeningeal metastases is poor and standard treatment, which includes radiotherapy and chemotherapy, is mostly ineffective. Melanoma represents one of the tumors with the highest incidence...

Cite
Simeone E, De Maio E, Sandomenico F, et al. Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report. J Med Case Rep. 2012;6:131doi: 10.1186/1752-1947-6-131.
Simeone, E., De Maio, E., Sandomenico, F., Fulciniti, F., Lastoria, S., Aprea, P., Staibano, S., Montesarchio, V., Palmieri, G., Mozzillo, N., & Ascierto, P. A. (2012). Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report. Journal of medical case reports, 6131. https://doi.org/10.1186/1752-1947-6-131
Simeone, Ester, et al. "Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report." Journal of medical case reports vol. 6 (2012): 131. doi: https://doi.org/10.1186/1752-1947-6-131
Simeone E, De Maio E, Sandomenico F, Fulciniti F, Lastoria S, Aprea P, Staibano S, Montesarchio V, Palmieri G, Mozzillo N, Ascierto PA. Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report. J Med Case Rep. 2012 May 17;6:131. doi: 10.1186/1752-1947-6-131. PMID: 22594466; PMCID: PMC3423050.
Copy Download .nbib Format: NLM
Behaviour of glyphosate in a reservoir and the surrounding agricultural soils.

The Science of the total environment

Maqueda C, Undabeytia T, Villaverde J, Morillo E.
PMID: 28364613
Sci Total Environ. 2017 Sep 01;593:787-795. doi: 10.1016/j.scitotenv.2017.03.202. Epub 2017 Mar 30.

Glyphosate (GPS) is an herbicide currently used on olive crops in Spain, and can be transported to the nearby reservoirs currently used for human consumption. The purpose of this work was to study the behaviour and environmental fate of...

Cite
Maqueda C, Undabeytia T, Villaverde J, et al. Behaviour of glyphosate in a reservoir and the surrounding agricultural soils. Sci Total Environ. 2017;593:787-795doi: 10.1016/j.scitotenv.2017.03.202.
Maqueda, C., Undabeytia, T., Villaverde, J., & Morillo, E. (2017). Behaviour of glyphosate in a reservoir and the surrounding agricultural soils. The Science of the total environment, 593787-795. https://doi.org/10.1016/j.scitotenv.2017.03.202
Maqueda, C, et al. "Behaviour of glyphosate in a reservoir and the surrounding agricultural soils." The Science of the total environment vol. 593 (2017): 787-795. doi: https://doi.org/10.1016/j.scitotenv.2017.03.202
Maqueda C, Undabeytia T, Villaverde J, Morillo E. Behaviour of glyphosate in a reservoir and the surrounding agricultural soils. Sci Total Environ. 2017 Sep 01;593:787-795. doi: 10.1016/j.scitotenv.2017.03.202. Epub 2017 Mar 30. PMID: 28364613.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 65 entries